Cargando…
In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes
BACKGROUND: Dalfampridine extended release tablets (dalfampridine-ER, known as prolonged-, modified, or sustained-release fampridine tablets in some countries) are approved for the improvement of walking in patients with multiple sclerosis (MS). Dalfampridine-ER is an extended release formulation of...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Maney Publishing
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937660/ https://www.ncbi.nlm.nih.gov/pubmed/27536444 http://dx.doi.org/10.3109/21556660.2013.818544 |